期刊
PHARMACEUTICS
卷 15, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/pharmaceutics15102412
关键词
human papillomavirus; cancer; PDT; curcumin; HNSCC; PLGA; liposomes; LED
Infection with HPV is a major risk factor for head and neck squamous cell carcinomas (HNSCCs), but photodynamic therapy (PDT) using CUR-LCNPs shows promise as an alternative treatment regardless of HPV status.
Next to alcohol and tobacco abuse, infection with human papillomaviruses (HPVs) is a major risk factor for developing head and neck squamous cell carcinomas (HNSCCs), leading to 350,000 casualties worldwide each year. Limited therapy options and drug resistance raise the urge for alternative methods such as photodynamic therapy (PDT), a minimally invasive procedure used to treat HNSCC and other cancers. We prepared lipid-coated polymeric nanoparticles encapsulating curcumin as the photosensitizer (CUR-LCNPs). The prepared CUR-LCNPs were in the nanometer range (153.37 +/- 1.58 nm) and showed an encapsulation efficiency of 92.69 +/- 0.03%. Proper lipid coating was visualized using atomic force microscopy (AFM). The CUR-LCNPs were tested in three HPVpos and three HPVneg HNSCC lines regarding their uptake capabilities and in vitro cell killing capacity, revealing a variable but highly significant tumor cell inhibiting effect in all tested HNSCC cell lines. No significant differences were detected between the HPVpos and HPVneg HNSCC groups (mean IC50: (9.34 +/- 4.73 mu mol/L vs. 6.88 +/- 1.03 mu mol/L), suggesting CUR-LCNPs/PDT to be a promising therapeutic option for HNSCC patients independent of their HPV status.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据